首页> 外国专利> Compositions comprising of interfering RNA molecules directed against beta adrenergic receptors.And use of said compositions for the treatment of pathologies associated with ocular hypertension.

Compositions comprising of interfering RNA molecules directed against beta adrenergic receptors.And use of said compositions for the treatment of pathologies associated with ocular hypertension.

机译:包含针对β肾上腺素能受体的干扰RNA分子的组合物,以及所述组合物在治疗与高眼压相关的病理学中的用途。

摘要

Composition for reducing expression of mRNA associated with ocular hypertension; use of the composition for the treatment of ocular hypertension; method to attenuate expression of a FirstWhite variant of ocular hypertension without reducing mrna expression of a Target mRNA of ocular hypertension.
机译:用于降低与高眼压有关的mRNA表达的组合物;该组合物在治疗高眼压症中的用途;减低高眼压的FirstWhite变体的表达而不降低高眼压的靶mRNA的mrna表达的方法。

著录项

  • 公开/公告号CL2006000220A1

    专利类型

  • 公开/公告日2007-07-13

    原文格式PDF

  • 申请/专利权人 ALCON INC.;

    申请/专利号CL2006000220

  • 申请日2006-02-01

  • 分类号A61K48/00;A61P27/02;

  • 国家 CL

  • 入库时间 2022-08-21 20:59:16

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号